| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $66,831,641 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012493 | Zambia Education Network for Implementation Science Training in Health (ZENITH) | 000 | 2 | NIH | 3/18/2024 | $50,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS127827 | Interoception and Pain: Noradrenergic Modulation of Nociceptive Transmission in the Parabrachial Nucleus | 001 | 2 | NIH | 4/9/2024 | $32,217 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS127827 | Interoception and Pain: Noradrenergic Modulation of Nociceptive Transmission in the Parabrachial Nucleus | 000 | 2 | NIH | 3/27/2024 | $414,229 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS129502 | Role of reactive astrocytes in prion diseases | 001 | 2 | NIH | 4/16/2024 | $43,578 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS129502 | Role of reactive astrocytes in prion diseases | 000 | 2 | NIH | 11/9/2023 | $560,291 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30AI174890 | Characterization of HIV-1 Genome Dimerization: A Strain Specific Dimerization Mechanism | 000 | 2 | NIH | 3/14/2024 | $52,694 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33AT009990 | Prebiotic Treatment in People with Schizophrenia | 000 | 4 | NIH | 2/23/2024 | $30,943 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21MH129809 | Estrogen modulation of the lateral habenula and its ability to inhibit midbrain dopamine neurons | 000 | 2 | NIH | 1/4/2024 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI172487 | Broadly neutralizing antibody combinations with single virions in HIV+ plasma | 000 | 2 | NIH | 12/5/2023 | $347,625 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA269995 | Nanotherapeutic enhancement of interstitial thermal therapy for glioblastoma | 001 | 2 | NIH | 4/17/2024 | $31,739 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA269995 | Nanotherapeutic enhancement of interstitial thermal therapy for glioblastoma | 000 | 2 | NIH | 11/16/2023 | $571,318 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25DE032530 | Maryland Program in Dental Research Experience (D-REX) | 000 | 2 | NIH | 12/14/2023 | $135,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 000 | 2 | NIH | 12/20/2023 | $503,935 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI176774 | Impact of infection complexity on P. falciparum sexual commitment and gametocytemia | 000 | 2 | NIH | 3/6/2024 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH129310 | Behavioral and neural mechanisms mediating social motivation in a rat model for ASD | 000 | 2 | NIH | 10/18/2023 | $398,666 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG079854 | Methods to Test Biomarkers of Aging as Shared Determinants of Alzheimers Disease and Related Dementias and Physical Disability | 000 | 2 | NIH | 11/10/2023 | $682,648 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162940 | Computational Modeling of Device-Induced Platelet Activation and Receptor Shedding Relevant to Thrombosis and Bleeding in Device-Assisted Circulation | 000 | 2 | NIH | 11/14/2023 | $461,563 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31DA057817 | Sex Differences in Endocannabinoid Regulation of Behavioral Flexibility | 000 | 2 | NIH | 11/16/2023 | $40,834 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA271540 | Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC | 001 | 2 | NIH | 4/18/2024 | $26,026 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA271540 | Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC | 000 | 2 | NIH | 12/15/2023 | $468,472 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL159973 | Beta-2 adrenergic signaling in immune homeostasis and reconstitution | 000 | 3 | NIH | 3/25/2024 | $689,422 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI172827 | Multi-Omics Characterization of Plasmodium Vivax Hypnozoites | 000 | 2 | NIH | 11/13/2023 | $634,512 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL167012 | A mechanistic understanding of treatment-related outcomes of sleep disordered breathing using functional near infrared spectroscopy | 000 | 2 | NIH | 2/16/2024 | $533,816 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 000 | 2 | NIH | 11/14/2023 | $586,642 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01ES033301 | Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney | 000 | 3 | NIH | 3/29/2024 | $363,710 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33AG076858 | Cell-type and organelle-specific multi-omics platform for the study of brain aging | 000 | 3 | NIH | 3/19/2024 | $600,629 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F32AI181170 | Prospective contributions of the vaginal microbiome and immune milieu to spontaneous Chlamydia trachomatis clearance | 000 | 1 | NIH | 3/28/2024 | $72,212 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD007982 | Racial and Ethnic Minority Acceleration for Health Equity Consortium U01 | 000 | 2 | FDA | 12/29/2023 | $50,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K99DA060209 | Postpartum Neurobiological Sequelae of Prescription Opioid Use During Pregnancy | 000 | 1 | NIH | 2/28/2024 | $178,322 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA270591 | Dual inhibition of PARP and STAT3 as a novel therapeutic approach for triple-negative breast cancer | 000 | 1 | NIH | 1/18/2024 | $230,361 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R13AI183722 | 14th International Bordetella Symposium | 000 | 1 | NIH | 3/1/2024 | $6,500 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R13HS029601 | ASTARISQ: Addressing systemic and STructurAl Racism to Improve Safety, Quality, and trustworthiness in health delivery systems | 000 | 1 | AHRQ | 2/19/2024 | $50,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R34AR084146 | A Planning Grant for a Multi-Center Randomized Controlled Trial Comparing Resection and Endoprosthetic Reconstruction vs. Internal Fixation for Metastatic Bone Disease of the Proximal Femur | 000 | 1 | NIH | 3/20/2024 | $160,560 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA279108 | The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer | 000 | 1 | NIH | 1/8/2024 | $656,397 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03HD114143 | Transcriptional Profiling of the Post-Stroke Immune Response to Tailor Rehabilitation Timelines | 000 | 1 | NIH | 1/31/2024 | $252,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH131566 | Reward, Salience and Value Processing in Youths at Risk for Psychosis: The RSVP Study | 000 | 1 | NIH | 2/16/2024 | $760,952 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21MH134017 | Regulation of BNST development by the adaptive immune system: implications for neurodevelopmental disorders | 000 | 1 | NIH | 4/1/2024 | $233,250 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA058438 | Cocaine Abstinence or Reduced Use May Retard Alterations in Brain Structure and Function, and Associated Cognitive Changes among African American Cocaine Users with HIV | 000 | 1 | NIH | 4/19/2024 | $939,459 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS134126 | Sex Differences in the Bed Nucleus of the Stria Terminalis Guide Differential Pain Susceptibility | 001 | 1 | NIH | 3/8/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS134126 | Sex Differences in the Bed Nucleus of the Stria Terminalis Guide Differential Pain Susceptibility | 000 | 1 | NIH | 3/8/2024 | $37,352 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR083363 | Lipid metabolism in the growth plate | 000 | 1 | NIH | 1/10/2024 | $535,718 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31DA060014 | A Novel Animal Model to Investigate the Effects of Delta-9 - Tetrahydrocannabinol in the Primary Visual Cortex of Ferrets. | 000 | 1 | NIH | 2/12/2024 | $41,294 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG081693 | Deep-Learning Enhanced ASL MRI For Early AD Assessment | 000 | 1 | NIH | 3/12/2024 | $775,807 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL171120 | High Mechanical Shear Stress-Induced Neutrophil Dysfunction in Mechanically Assisted Circulation | 000 | 1 | NIH | 11/24/2023 | $516,895 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL168775 | Airway epithelial cytoglobin regulates nitric oxide synthase and development of primary ciliary dyskinesia and situs inversus | 000 | 1 | NIH | 12/1/2023 | $655,106 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 001 | 1 | NIH | 3/19/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 000 | 1 | NIH | 3/19/2024 | $35,058 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R36HS030034 | Towards a Better Understanding of Access Factors Associated with Treatment and Outcomes among Medicaid Enrollees with Opioid Use Disorder and Depression | 000 | 1 | AHRQ | 2/26/2024 | $38,012 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 000 | 1 | NIH | 12/11/2023 | $639,330 |
|